{"text": "Section 1: Ketamine-Based Therapies\n\nKetamine-based therapies have emerged as a promising treatment option for\n\nbipolar depression with psychotic episodes. Research has shown that\n\nketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, can rapidly\n\nalleviate symptoms of depression and psychosis in individuals with bipolar\n\ndisorder (1).\n\nStudies have demonstrated that ketamine infusions can lead to significant\n\nimprovements in depressive symptoms within 24 hours, with effects lasting up", "embedding": []}